137 related articles for article (PubMed ID: 1926674)
1. [High-dose trospium chloride in therapy of detrusor hyperreflexia].
Madersbacher H; Stöhrer M; Richter R; Giannetti BM; Mürtz G
Urologe A; 1991 Jul; 30(4):260-3. PubMed ID: 1926674
[TBL] [Abstract][Full Text] [Related]
2. Trospium chloride in patients with detrusor overactivity: meta-analysis of placebo-controlled, randomized, double-blind, multi-center clinical trials on the efficacy and safety of 20 mg trospium chloride twice daily.
Fröhlich G; Bulitta M; Strösser W
Int J Clin Pharmacol Ther; 2002 Jul; 40(7):295-303. PubMed ID: 12139206
[TBL] [Abstract][Full Text] [Related]
3. Trospium chloride in patients with neurogenic detrusor overactivity: is dose titration of benefit to the patients?
Menarini M; Del Popolo G; Di Benedetto P; Haselmann J; Bödeker RH; Schwantes U; Madersbacher H;
Int J Clin Pharmacol Ther; 2006 Dec; 44(12):623-32. PubMed ID: 17190372
[TBL] [Abstract][Full Text] [Related]
4. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
[TBL] [Abstract][Full Text] [Related]
5. [Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test].
Fröhlich G; Burmeister S; Wiedemann A; Bulitta M
Arzneimittelforschung; 1998 May; 48(5):486-91. PubMed ID: 9638316
[TBL] [Abstract][Full Text] [Related]
6. Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebo-controlled double-blind trial.
Stöhrer M; Bauer P; Giannetti BM; Richter R; Burgdörfer H; Mürtz G
Urol Int; 1991; 47(3):138-43. PubMed ID: 1771701
[TBL] [Abstract][Full Text] [Related]
7. Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects.
Amend B; Hennenlotter J; Schäfer T; Horstmann M; Stenzl A; Sievert KD
Eur Urol; 2008 May; 53(5):1021-8. PubMed ID: 18243516
[TBL] [Abstract][Full Text] [Related]
8. [Trospium chloride (spasmex) in the treatment of lower urinary tract symptoms in patients with neurogenic hyperactive urinary bladder caused by vertebrogenic lesions].
Mazo EB; Babanina GA
Urologiia; 2007; (3):15-9. PubMed ID: 17722614
[TBL] [Abstract][Full Text] [Related]
9. [Experience with application of trospium chloride in patients with neurogenic detrusor overactivity].
Shvarts PG; Kadykov AS; Shvedkov VV; Timerbaeva SL; Polevaia EV; Mulach AN
Urologiia; 2009; (5):24-9. PubMed ID: 20213911
[TBL] [Abstract][Full Text] [Related]
10. [Trospium chloride in the treatment of idiopathic and neurogenic detrusor overactivity].
Mazo EB; Krivoborodov GG; Shkol'nikov ME; Babanina GA; Kozyrev SV; Korshunov ES
Urologiia; 2005; (4):56-9. PubMed ID: 16158750
[TBL] [Abstract][Full Text] [Related]
11. Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage.
Horstmann M; Schaefer T; Aguilar Y; Stenzl A; Sievert KD
Neurourol Urodyn; 2006; 25(5):441-5. PubMed ID: 16847942
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and urodynamic effects of oral propiverine therapy in neurogenic urinary incontinence. A multicenter study for optimizing dosage].
Mazur D; Göcking K; Wehnert J; Schubert G; Herfurth G; Alken RG
Urologe A; 1994 Sep; 33(5):447-52. PubMed ID: 7974935
[TBL] [Abstract][Full Text] [Related]
13. Effects of ZD6169 and ZD0947, 2 potassium adenosine triphosphate channel openers, on bladder function of spinalized rats.
Abdel-Karim AM; Bialecki RA; Elhilali MM
J Urol; 2002 Aug; 168(2):837-42. PubMed ID: 12131377
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia--a double-blind, placebo-controlled clinical trial.
Stöhrer M; Madersbacher H; Richter R; Wehnert J; Dreikorn K
Spinal Cord; 1999 Mar; 37(3):196-200. PubMed ID: 10213329
[TBL] [Abstract][Full Text] [Related]
15. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH;
Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
[TBL] [Abstract][Full Text] [Related]
16. Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial.
Staskin D; Sand P; Zinner N; Dmochowski R;
J Urol; 2007 Sep; 178(3 Pt 1):978-83; discussion 983-4. PubMed ID: 17632131
[TBL] [Abstract][Full Text] [Related]
17. Trospium chloride for the treatment of overactive bladder with urge incontinence.
Singh-Franco D; Machado C; Tuteja S; Zapantis A
Clin Ther; 2005 May; 27(5):511-30. PubMed ID: 15978301
[TBL] [Abstract][Full Text] [Related]
18. Evidence of a peripheral role of neurokinins in detrusor hyperreflexia: a further study of selective tachykinin antagonists in chronic spinal injured rats.
Abdel-Gawad M; Dion SB; Elhilali MM
J Urol; 2001 May; 165(5):1739-44. PubMed ID: 11342967
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions.
Klaphajone J; Kitisomprayoonkul W; Sriplakit S
Arch Phys Med Rehabil; 2005 Nov; 86(11):2114-8. PubMed ID: 16271557
[TBL] [Abstract][Full Text] [Related]
20. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.
Akbar M; Abel R; Seyler TM; Bedke J; Haferkamp A; Gerner HJ; Möhring K
BJU Int; 2007 Sep; 100(3):639-45. PubMed ID: 17532858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
